Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
57
HRTS Quote, Financials, Valuation and Earnings
Last price:
$35.10
Seasonality move
:
-7.7%
Day range:
$35.19 - $35.50
52-week range:
$25.32 - $36.65
Dividend yield:
1.33%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.7K
Avg. volume:
9K
1-year change:
16.74%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
|
OZEM
Roundhill GLP-1 & Weight Loss ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
$35.50 | -- | -- | -- | $0.47 | 1.33% | -- |
|
AGNG
Global X Aging Population ETF
|
$37.36 | -- | -- | -- | $0.17 | 0.84% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$30.45 | -- | -- | -- | $0.01 | 0% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$34.75 | -- | -- | -- | $0.41 | 1.18% | -- |
|
OZEM
Roundhill GLP-1 & Weight Loss ETF
|
$32.67 | -- | -- | -- | $0.41 | 1.26% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$25.41 | -- | -- | -- | $0.41 | 1.63% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | 0.247 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.225 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 0.614 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.120 | -- | -- |
|
OZEM
Roundhill GLP-1 & Weight Loss ETF
|
-- | 0.652 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.745 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
|
OZEM
Roundhill GLP-1 & Weight Loss ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
Tema Heart & Health ETF vs. Competitors
-
Which has Higher Returns HRTS or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HRTS or AGNG?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema Heart & Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HRTS or AGNG More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.142%.
-
Which is a Better Dividend Stock HRTS or AGNG?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.33%. Global X Aging Population ETF offers a yield of 0.84% to investors and pays a quarterly dividend of $0.17 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or AGNG?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HRTS or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About HRTS or BMED?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe Tema Heart & Health ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is HRTS or BMED More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.892, suggesting its less volatile than the S&P 500 by 10.827%.
-
Which is a Better Dividend Stock HRTS or BMED?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.33%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or BMED?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns HRTS or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About HRTS or MEDX?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema Heart & Health ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is HRTS or MEDX More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or MEDX?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.33%. Horizon Kinetics Medical ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $0.41 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or MEDX?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
-
Which has Higher Returns HRTS or OZEM?
Roundhill GLP-1 & Weight Loss ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Roundhill GLP-1 & Weight Loss ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- OZEMRoundhill GLP-1 & Weight Loss ETF-- -- -- -
What do Analysts Say About HRTS or OZEM?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Roundhill GLP-1 & Weight Loss ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Roundhill GLP-1 & Weight Loss ETF, analysts believe Tema Heart & Health ETF is more attractive than Roundhill GLP-1 & Weight Loss ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 OZEMRoundhill GLP-1 & Weight Loss ETF0 0 0 -
Is HRTS or OZEM More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Roundhill GLP-1 & Weight Loss ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or OZEM?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.33%. Roundhill GLP-1 & Weight Loss ETF offers a yield of 1.26% to investors and pays a quarterly dividend of $0.41 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Roundhill GLP-1 & Weight Loss ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or OZEM?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Roundhill GLP-1 & Weight Loss ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Roundhill GLP-1 & Weight Loss ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Roundhill GLP-1 & Weight Loss ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Roundhill GLP-1 & Weight Loss ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- OZEMRoundhill GLP-1 & Weight Loss ETF-- -- -- --
-
Which has Higher Returns HRTS or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About HRTS or THNR?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe Tema Heart & Health ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is HRTS or THNR More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or THNR?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 1.33%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 1.63% to investors and pays a quarterly dividend of $0.41 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or THNR?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
93
NBTX alert for Mar 5
Nanobiotix SA [NBTX] is down 7.15% over the past day.
Sell
45
MRNA alert for Mar 5
Moderna, Inc. [MRNA] is down 6.83% over the past day.
Buy
77
SSRM alert for Mar 5
SSR Mining, Inc. [SSRM] is down 6.13% over the past day.
